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Abstract
Background: Late referral to specialist nephrological care is associated with increased morbidity,
mortality, and cost. Consequently, nephrologists' associations recommend early referral. The
recommendations' effectiveness remains questionable: 22–51% of referrals need renal replacement
therapy (RRT) within 3–4 months. This may be due to these recommendations addressing the
specialist, rather than the primary care providers (PCP).
The potential of specialist intervention aiming at slowing progression of chronic renal failure was
introduced individually to some 250 local PCPs, and referral strategies were discussed. To
overcome the PCPs' most often expressed fears, every referred patient was asked to report back
to his PCP immediately after the initial specialist examination, and new medications were
prescribed directly, and thus allotted to the nephrologist's budget.
Methods: In retrospective analysis, the stage of renal disease in patients referred within three
months before the introductory round (group A, n = 18), was compared to referrals two years
later (group B, n = 50).
Results: Relative number of patients remained stable (28%) for mild/ moderate chronic kidney
disease (MMCKD), while there was a noticeable shift from patients referred severe chronic kidney
disease (SCKD) (group A: 44%, group B: 20%) to patients referred in moderate chronic kidney
disease (MCKD) (group A: 28%, group B: 52%).
Conclusion:  Individually addressing PCPs' ignorance and concerns noticeably decreased late
referral. This stresses the importance of enhancing the PCPs' problem awareness and knowledge
of available resources in order to ensure timely specialist referral.
Background
Late referral to specialist care for renal failure is associated
with increased morbidity, mortality, and cost (review
in[1,2]). Consequently, nephrologists' associations rec-
ommend early referral[3,4]. The recently published ERA/
EDTA guideline states: "Referral to nephrology should be
considered when the GFR is <60 ml/min and is manda-
tory when the GFR is <30 ml/min"[3]. The recommenda-
tions' effectiveness remains questionable: 22–51% of
patients need renal replacement therapy (RRT) within 3–
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4 months [5,6] after first referral to specialist nephrologi-
cal care.
Chronic renal disease may be asymptomatic for a very
long time. This stresses the importance of primary care
providers in ensuring timely referral to a renal care center.
Levin[1] reviewed aspects of the referral process and noted
that the consequences of late referral were usually and
most specifically described in specialist nephrological
journals, thus not reaching the necessary target audience,
the primary care providers (PCPs).
The problem of late referral seems to be ubiquitous, if dis-
cussions with colleagues world- wide may be believed,
and has led to numerous local, regional and national ini-
tiatives aiming at ensuring timely referral into specialist
care. Some initiatives[7,8] successfully bypass the PCPs by
introducing population screening programs, while others
opt for the alternative of "managed care"[9].
This article summarizes findings from a local initiative
started by one of the authors (K.H.) in 1997 in the city of
Dortmund, Germany.
In Germany, about 90% of the population are covered by
the mandatory health insurance system ("Gesetzliche
Krankenversicherung"). All physicians who wish to treat
these patients are organized in associations, which nego-
tiate a budget with the insurance companies. Depending
on the specialty, a typical per capita budget is then
assigned per patient for a period of three months. This
budget covers consultation fees, and the cost of medica-
tion prescribed. If a physicians exceeds the total budget
thus calculated for his practice, the insurance companies
can demand restoration of funds. Typically, a GP's per
patient budget would be much lower than a nephrolo-
gist's. During the time period described here, the nephrol-
ogist's budget per patient was about ten times as much
than a general practitioner's. While this budget strategy is
intended as a safeguard against excess prescriptions, it has
been criticized by many physicians for inducing sub- opti-
mal treatment as practice owners comply rather with
budget demands than with best practice guidelines.
Dortmund, a town of 589000, has a physician to patient
ratio of 141/ 100000 (German average: 156/ 100000).
There are five nephrological centers, including two hospi-
tals. Currently, 172 general practioners ("Allgemeinärzte
und Praktische Ärzte"), 123 internists ("Ärzte für Innere
Medizin") and 21 urologists are listed in Dortmund. One
of the internist practices supervises a dialysis center, but
does not provide specialized nephrological consultancy.
GPs, internists and urologists were considered primary
care providers, as all referrals for treatment of chronic
renal failures came from one of these specialties. There
were no major fluctuations of physician numbers between
1997 and 1999, the period for which data was analyzed
here.
Joint initiatives by all five nephrology centres in Dort-
mund to give PCPs a series of lectures on treatment of
chronic renal disease met with little response, as the pre-
senters regularly outnumbered the audience. In the spirit
of the Declaration of Helsinki, part II.1.: ("In the treat-
ment of the sick persons, the doctor must be free to use a
new therapeutic measure, if in the doctor's judgment it
offers hope of saving life, reestablishing health, or allevi-
ating suffering")[10], K.H. decided to take active measures
to induce PCPs to refer patients at an earlier stage.
In order to do so, education was brought to the primary
care providers, as opposed to bringing the PCPs to educa-
tion. Over a period of 18 months, K.H. introduced himself
and the potential of timely nephrological care in delaying
or even halting the progression of chronic renal disease to
PCPs- General Practitioners, and specialists in Internal
Medicine and Urology. This introductory round included
participation in local PCPs' round tables and PCP organ-
ized continuous medical education events, but also indi-
vidually meeting some 250 PCPs for discussion. During
these sessions, the topic of renal disease was subtly intro-
duced during discussions on the more common diseases
and risk factors, such as cardiovascular disease, hyperten-
sion and diabetes mellitus.
During these teaching sessions and discussions, three
arguments were repeatedly brought forward by the PCPs:
1. Mild- moderate renal failure should be treated by the
primary care providers, while the nephrologists' task was
seen in providing renal replacement therapy.
2. Referral to specialist care meant risking the loss of the
patient to the specialist's practice (In Germany, direct spe-
cialist access is possible, and patients tend to stay with one
doctor if satisfied).
3. If patients did return from specialist consultation, they
were usually carrying recommendations for costly perma-
nent medication, such as ACE inhibitors, that put a heavy
burden on the PCP's budget.
The first of these arguments was addressed by the "teach-
ing module" of the visits. PCPs were given an executive
summary of the complexities of diagnostic and therapeu-
tic procedures used in state- of- the- art nephrology, and
the potential of intensified treatment by specialists aiming
at slowing the progression of renal failure was explained
in detail.BMC Nephrology 2004, 5:16 http://www.biomedcentral.com/1471-2369/5/16
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Secondly, all patients referred were asked to report back to
the referring PCP within one week of the consultation, by
which time a summary of findings and appropriate coun-
sel had been sent ahead.
Thirdly, instead of drug recommendations, drug prescriptions
were handed out directly and so allotted to the much
higher nephrologist's budget, thus easing the financial
pressure on the primary care providers. More importantly,
also the follow- up prescriptions were done in the renal
care center, so that at no time the PCPs budget became
endangered.
The present study investigates the question whether
improving the PCP's knowledge about the potential of
timely treatment of chronic renal failure, in combination
with addressing their economic concerns, succeeded in
encouraging timely referral to specialist care.
Methods
Retrospective analysis of patients' records. Analysis of
patient records was carried out by a final year medical stu-
dent (TDV). All patients had agreed to have their data
used for quality control measures at the time of referral.
Specifically informed consent was obtained from all
patients still alive at the time of data collection. Two
groups were selected by date of first contact with the neph-
rologist: Group A, third quarter 1997, immediately before
the start of the initiative, and Group B, third quarter 1999,
six months after the last visit to a primary care provider
had taken place. All new patients whose records indicated
referral for nephrological specialist treatment were
included in the study. Criteria were subnormal creatinine
clearance (ECC) or elevated serum creatinine, elevated
blood pressure, proteinuria, or erythrocyturia. The
patients in each of the two groups were divided into three
subgroups according to their renal function: mild/moder-
ate chronic kidney disease (MMCKD), ECC > 60 ml/min/
1.73 m2, moderate chronic kidney disease (MCKD), 60
ml/min/1.73 m2 > ECC > 20 ml/min/1.73 m2, and severe
chronic renal disease (SCKD), ECC < 20 ml/min/1.73 m2.
Due to small proband numbers in the subgroups, the null
hypothesis ("no inter- group differences") was tested by
the non- parametric, two sided Chi- square test. Survival
was estimated by Kaplan- Meier analysis. Statistical analy-
sis was carried out using the SPSS v11.5 package.
Results
Table 1 and 2 show the descriptive statistics of two groups,
including gender and age distribution, diagnosis, preva-
lence of diabetes, and biopsy frequency. Individually
addressing PCPs ignorance and concerns decreased late
referral, from the high (SCKD: 44%) to the low (SCKD:
20%) end of the spectrum in published data[5,6] (Chi-
square test: 2-sided p = 0.09), as detailed in Figure 1. The
relative share of patients seen at the stage of moderate
CKD increased, while the relative percentage of patients
seen in mild/moderate CKD remained stable. The health
outcome (survival in MMCKD and MCKD groups) of
patients was insignificantly improved: the mean survival
time in group A is 1.71 yrs (1.30–2.12 yrs) compared to a
mean survival of 1.90 yrs (1.78–2.02 yrs) in group B.
Discussion
The present study is a retrospective analysis of patient data
from a single nephrological referral centre, and statistics
are carried out on a data set of limited size (n = 18 only in
the pre- intervention group A). As such, the statistical sig-
nificance of the findings is doubtful, and the results might
be interpreted as akin to a case report, or a medical
anecdote.
As such, however, it may have a value quite different from,
but equal to that of a randomized, controlled study.
Table 1: Age and gender distribution in the two cohorts.
Group A: n= 18
MMCKD: n= 5 (28%) MCKD: n= 5 (28%) SCKD: n= 8 (44%)
MF MF MF
Gender (n/ %) 3/ (60%) 2/ (40%) 4/ (80%) 1/ (20%) 4/ (50%) 4/ (50%)
Age (yrs ± SD) 59.7 ± 10.7 44.0 ± 11.3 59.5 ± 20.7 26.0 ± 0.0 55.3 ± 27.2 72.5 ± 8.3
Group B: n= 50
MMCKD: n= 14 (28%) MCKD: n= 26 (52%) SCKD: n= 10 (20%)
MF MF MF
Gender (n/ %) 11/ (78.6%) 3/ (21.4%) 17/ (65.4%) 9/ (34.6%) 1/ (10.0%) 9/ (90%)
Age (yrs ± SD) 32.7 ± 16.1 25.0 ± 17.6 60.9 ± 12.6 54.8 ± 11.8 75.0 ± 0.0 65.4 ± 13.2BMC Nephrology 2004, 5:16 http://www.biomedcentral.com/1471-2369/5/16
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Aronson recently discussed the value of medical anec-
dotes[11]; of the eight reasons listed there, the present
study meets four: it generates a hypothesis (i.e., close com-
munication with PCPs leads to earlier referral to specialist
nephrological care), it suggests a method of management
(i.e., individualized teaching sessions and adoption of
financial incentives to increase early referral), it reminds
and educates (i.e., of the benefit of early referral), and it
hopes to stimulate a systematic review (i.e., the authors
hope that the results will entice larger dialysis providers to
design and carry out a prospective, randomized study).
More often than not, observational studies give similar
results to controlled randomized trials[12,13], and critical
appraisal of this notion leads to the conclusion that, while
good controlled randomized trials do provide the highest
level of evidence, a flexible approach may be taken "in
which randomised controlled trials and observational
studies have complementary roles. High quality observa-
tional studies may extend evidence over a wider popula-
tion and are likely to be dominant in the identification of
harms and when randomised controlled trials would be
unethical or impractical"[14].
The positive finding of the present study is that active
recruiting strategies may improve the referral pattern. Fol-
lowing the discussions with individual PCPs, more
patients were referred to specialist care at a stage where
appropriate treatment may slow or even halt the progres-
sion of chronic renal failure. This should benefit first the
patient, and then in the long run society as a whole.
Recent studies[2,15] have shown that early referral causes
a substantial decrease in hospitalization costs in the first
year after referral. It is very probable that adequate treat-
ment and therefore prolongation of the pre- dialysis mod-
erate CKD stage will incur reduced overall spending; the
increase in quality of life for the patients is immeasurable.
Due to the relatively small number of patients available in
this single centre study, combined with the short follow-
up interval of just two years, only a slight trend towards
prolonged "survival" as defined above could be demon-
strated. An American multi- centre study[16] has recently
shown, however, that late referral is clearly associated
with higher morbidity. To what extend the timing of dial-
ysis initiation influences survival remains as yet question-
able. By contrast, Traynor[17] recently demonstrated that
early initiation of dialysis may even be detrimental. There
is currently one controlled, randomized study addressing
this question[18], and the perspective may change once
high level evidence is obtained.
Late referral to specialist care in chronic renal disease
remains a problem world- wide. As early as 1984, focusing
on the question under which circumstances renal replace-
ment therapy should be initiated or not, questionnaires
showed significant differences in the attitudes of nephrol-
ogists and non- nephrologists towards referral[19] in the
United Kingdom, and this difference in behavior has
decreased, but not been eradicated over time[20]. Similar
observations were made in Canada[1], and the United
States [21].
It has been speculated that this may be because these rec-
ommendations address the specialist, rather than the pri-
mary care providers (PCP)[1,2].
At present, a medline search using the keywords "referral"
and "chronic renal failure" listed a total of 81 references
since 1974, with only 48 in specialist, not necessarily
nephrological journals, while adding "guideline" reduced
Table 2: Diagnosis of patients referred for specialist nephrological evaluation.
Group A, n = 18 count (% within group) Group B, n = 50 count (% within group)
Diagnosis No renal failure 0 (0%) 13 (26%)
Glomerulonephritis 4 (22.2%) 5 (10%)
Diabetes 3 (16.7%) 8 (16%)
Nephrosklerosis 2 (11.1%) 4 (8%)
Lupus 1 (5.6%) 0 (0%)
Nephrectomy 2 (11.1%) 4 (8%)
Renal cirrhosis 2 (11.1%) 4 (8%)
Reflux 0 (.0%) 1 (2%)
Polycystic disease 1 (5.6%) 1 (2%)
Others 1 (5.6%) 3 (6%)
Unknown cause 2 (11.1%) 7 (14%)
Diabetes No 12 (66.7%) 30 (62.5%)
Yes 6 (33.3%) 18 (37.5%)
Biopsy No 15 (83.3%) 40 (83.3%)
Yes 3 (16.7%) 8 (16.7%)BMC Nephrology 2004, 5:16 http://www.biomedcentral.com/1471-2369/5/16
Page 5 of 7
(page number not for citation purposes)
the reference list to a disappointing three references from
the years 1998 and 1999, which included, however, a fully
accessible online guideline in the Canadian Medical Asso-
ciation's journal. Neither the American, nor the European
Renal Associations' guidelines[3,4] were found by these
obvious search strategies. Only the former was found by
the search terms "guideline" and "kidney disease", leading
to the relevant article in the American Journal of Kidney
Disease, accessible only to subscribers.
Better results were obtained using the same search terms
on a general search engine (Google), leading at first hit to
the DOQI webpage, which includes the free access to full
text guidelines. An extensive search using the same terms
in German, however, showed no relevant results but an
abundance of lay articles of dubious quality. This scarcity
of qualified information might exclude those physicians
not fluent in English from gathering relevant and up- to-
date information. National renal care associations should
therefore consider extending their educational efforts
beyond their specialist members and selectively target
PCPs and their respective professional associations.
In the present study, two arguments brought forward by
PCPs to explain their reluctance to refer early focused on
the economic burden this presented to their own practice,
rather than society as a whole. These two arguments con-
cerned budget penalties if too much money was spent on
the (costly) pre- dialytic patients with chronic kidney dis-
Relative distribution (% of total) of patients into the three subgroups of MMCKD, MCKD and SCKD as defined under  "methods" Figure 1
Relative distribution (% of total) of patients into the three subgroups of MMCKD, MCKD and SCKD as defined under "meth-
ods". Distribution into MCKD and SCKD is inversed after intervention while MMCKD remains stable. Group A: patients 
referred in 1997; Group B: patients referred in 1999.BMC Nephrology 2004, 5:16 http://www.biomedcentral.com/1471-2369/5/16
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ease, and loss of patients after referral. This is an unusually
frank statement.
The majority of 22 medline hits using the search terms
"economy" and "renal disease" address the question of
best cost- efficiency of treatment strategies on a macro-
economic level. Micro- economic considerations in the
distribution of health care are only hinted at[2]. Health
care planners increasingly stress economic factors. While
their laudable aim is to provide affordable treatment
options to the general population, the drawback of this
approach becomes obvious in situations as these, where a
conflict of interest arises between best practice and best
revenue.
Due to the retrospective design of this study, one cannot
analyze to what extent the PCPs' economic considerations
rather than their educational state were responsible for
their referral pattern. The fact that financial concerns were
the tenor of the individual discussions, however, indicates
that health care planners may profit from taking this into
account.
The authors hope that this single- centre study will entice
multi- centre RRT providers to conduct a prospective,
large scale study to further investigate the relative contri-
bution of the factors discussed here.
Conclusions
The initiative presented here shows that timely specialist
referral in renal care can be achieved. National and
regional differences in the organization of health care pro-
vision may lead to variant strategies to implement opti-
mal health care, but close collaboration with the primary
care providers is essential.
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